Cart
sales@molnova.com
Nitecapone
CAS No. 116313-94-1
Nitecapone ( —— )
Catalog No. M21089 CAS No. 116313-94-1
Nitecapone is a reversible inhibitor of S-COMT (IC50 values of 300 nM in rat liver).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 88 | Get Quote |
|
| 5MG | 155 | Get Quote |
|
| 10MG | 259 | Get Quote |
|
| 25MG | 440 | Get Quote |
|
| 50MG | 617 | Get Quote |
|
| 100MG | 851 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNitecapone
-
NoteResearch use only not for human use.
-
Brief DescriptionNitecapone is a reversible inhibitor of S-COMT (IC50 values of 300 nM in rat liver).
-
DescriptionNitecapone is a reversible inhibitor of S-COMT (IC50 values of 300 nM in rat liver).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorS-COMT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number116313-94-1
-
Formula Weight265.22
-
Molecular FormulaC12H11NO6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O
-
Chemical Name3-(34-Dihydroxy-5-nitrobenzylidene)-24-pentanedione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.P.T. M?nnist? Kaakkola S . Catechol-O-methyltransferase (COMT): Biochemistry molecular biology pharmacology and clinical efficacy of the new selective COMT inhibitors[J]. Pharmacological Reviews 2000 51(4):593-628.
molnova catalog
related products
-
Di-O-methylcrenatin
Di-O-methylcrenatin is a natural product of Photinia, Rosaceae. Di-O-methylcrenatin can be used as a reference standard.
-
GAK inhibitor 49
GAK inhibitor 49 is a highly selective and ATP-competitive cyclin G associated kinase (GAK) inhibitor (IC50: 56 nM; Ki: 0.54 nM ).
-
L-allo-Isoleucine
L-alloisoleucine is a branched chain amino acid and is a stereoisomer of L-isoleucine. It is a common constituent of human plasma (albeit at low levels). L-alloisoleucine is produced as a byproduct of isoleucine transamination. Plasma L-alloisoleucine which is derived from L-isoleucine in vivo can be used for the diagnosis of maple syrup urine disease (MSUD) a genetic disorder.
